Vertex Pharmaceuticals (VRTX +1.4%) gains after announcing earlier that the Health Service...
Friday, February 1, 2:11 PM ETVertex Pharmaceuticals (VRTX +1.4%) gains after announcing earlier that the Health Service Executive in the Republic of Ireland will fund Kalydeco. The drug is the first to treat the underlying cause of cystic fibrosis for people ages 6 and older who have at least one copy of the G551D mutation in the cystic fibrosis transmembrane conductance regulator gene, and helps the defective protein function more normally.
HEALTHCARE ETFs IN FOCUS
Latest Healthcare Articles